Schrödinger to Present at Jefferies London Healthcare Conference

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) announced its participation in the Jefferies London Healthcare Conference, with a pre-recorded fireside chat presentation accessible on November 18, 2021, after 8:00 a.m. GMT. The webcast will be available on their website and archived for about 14 days. The company is recognized for its physics-based software platform that accelerates the discovery of therapeutics and materials, aiding biopharmaceutical firms and academic institutions globally. Founded in 1990, Schrödinger operates in over 70 countries with a team of over 500 employees.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The pre-recorded presentation will be available on Thursday, November 18, 2021, after 8:00 a.m. GMT / 3:00 a.m. ET.

The “on demand” webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately 14 days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005416/en/

Jaren Irene Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

What is the date of Schrödinger's presentation at the Jefferies London Healthcare Conference?

Schrödinger's pre-recorded presentation will be available on November 18, 2021.

Where can I access the webcast of Schrödinger's presentation at the conference?

The webcast can be accessed under 'News & Events' in the investors section of Schrödinger's website.

How long will the webcast of Schrödinger's presentation be available?

The webcast will be archived for approximately 14 days.

What is the main focus of Schrödinger's business?

Schrödinger focuses on transforming therapeutics and materials discovery through a physics-based software platform.

How many countries does Schrödinger operate in?

Schrödinger operates in more than 70 countries worldwide.